Haiyan Ma

488 total citations
11 papers, 304 citations indexed

About

Haiyan Ma is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Haiyan Ma has authored 11 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Immunology. Recurrent topics in Haiyan Ma's work include Cytokine Signaling Pathways and Interactions (6 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Medicinal Plant Pharmacodynamics Research (2 papers). Haiyan Ma is often cited by papers focused on Cytokine Signaling Pathways and Interactions (6 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Medicinal Plant Pharmacodynamics Research (2 papers). Haiyan Ma collaborates with scholars based in China, United States and Hong Kong. Haiyan Ma's co-authors include Li Lin, Chenglong Li, Jiayuh Lin, Yina Wang, Sheng Li, Tianshu Liu, Jiagao Lv, Wei Shi, David Jou and Dan Yan and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Haiyan Ma

11 papers receiving 303 citations

Peers

Haiyan Ma

MB

ONCOL

IMMUN

CR

PRM

Marwa Kamel Egypt

Li Liang China

Wanfu Lin China

Hali Li China

Huiyan Niu China

Cui-Hong Zhu China

Win Lwin Thuya Singapore

Mi‐Hyeon Jeong South Korea

Wence Zhou China

Marwa Kamel Egypt

Haiyan Ma

137 ×1.0

MB

64 ×0.6

ONCOL

49 ×1.0

IMMUN

65 ×1.4

CR

29 ×0.8

PRM

Citations per year, relative to Haiyan Ma Haiyan Ma (= 1×) peers Marwa Kamel

Countries citing papers authored by Haiyan Ma

Since Specialization

Citations

This map shows the geographic impact of Haiyan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiyan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiyan Ma more than expected).

Fields of papers citing papers by Haiyan Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiyan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiyan Ma. The network helps show where Haiyan Ma may publish in the future.

Co-authorship network of co-authors of Haiyan Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Haiyan Ma. A scholar is included among the top collaborators of Haiyan Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiyan Ma. Haiyan Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Shi, Haifeng, Xi Sun, Haiyan Ma, et al.. (2020). Cadmium induces epithelial–mesenchymal transition and migration of renal cancer cells by increasing PGE2 through a cAMP/PKA-COX2 dependent mechanism. Ecotoxicology and Environmental Safety. 207. 111480–111480. 26 indexed citations

2.

Yan, Dan, Haiyan Ma, Wei Shi, et al.. (2020). Bazedoxifene Attenuates Abdominal Aortic Aneurysm Formation via Downregulation of Interleukin-6/Glycoprotein 130/Signal Transducer and Activator of Transcription 3 Signaling Pathway in Apolipoprotein E–Knockout Mice. Frontiers in Pharmacology. 11. 392–392. 14 indexed citations

3.

Luo, Pengcheng, Yina Wang, Junyi Guo, et al.. (2020). Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6/IL-6R/STAT3 signaling. European Journal of Pharmacology. 893. 173822–173822. 26 indexed citations

4.

Shi, Wei, Haiyan Ma, Tianshu Liu, et al.. (2020). Inhibition of Interleukin‐6/glycoprotein 130 signalling by Bazedoxifene ameliorates cardiac remodelling in pressure overload mice. Journal of Cellular and Molecular Medicine. 24(8). 4748–4761. 17 indexed citations

5.

Luo, Pengcheng, Wei Shi, Yina Wang, et al.. (2020). Raloxifene inhibits IL-6/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE−/− mice. Life Sciences. 261. 118304–118304. 21 indexed citations

6.

Guo, Junyi, Haiyan Ma, Wei Shi, et al.. (2018). Ursolic acid prevents angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-knockout mice. Atherosclerosis. 271. 128–135. 16 indexed citations

7.

Shi, Wei, Dan Yan, Yina Wang, et al.. (2017). Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista. Biochemical and Biophysical Research Communications. 491(1). 159–165. 27 indexed citations

8.

Liu, Tianshu, Haiyan Ma, Wei Shi, et al.. (2017). Inhibition of STAT3 signaling pathway by ursolic acid suppresses growth of hepatocellular carcinoma. International Journal of Oncology. 51(2). 555–562. 53 indexed citations

9.

Wang, Yina, Haiyan Ma, Tianshu Liu, et al.. (2017). Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling. Oncotarget. 8(20). 33683–33693. 14 indexed citations

10.

Lin, Li, David Jou, Yina Wang, et al.. (2016). STAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cells. International Journal of Oncology. 49(6). 2265–2274. 52 indexed citations

11.

Wang, Wenlong, Wenying Yu, David Jou, et al.. (2016). A novel small molecule STAT3 inhibitor, LY5, inhibits cell viability, colony formation, and migration of colon and liver cancer cells. Oncotarget. 7(11). 12917–12926. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact